Can You Get Rid of HPV? What Clearance, Follow-Up, and the Vaccine Mean for You

How does the immune system handle an HPV infection?

HPV (human papillomavirus) is a family of more than 100 related viruses, and most sexually active people will encounter at least one type at some point. The body's immune system recognizes HPV and, in most cases, suppresses the infection to undetectable levels over months to a year or two. Clinicians describe this as the virus "clearing," though it may technically become dormant rather than fully eliminated.

After clearance, viral load drops below what current tests can detect, and the risk of transmission or progression to cell changes becomes very low 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.HPV natural history, strain classification (low-risk vs high-risk), treatment of genital warts, immune clearance, and monitoring recommendations for immunocompromised individuals. This expected outcome applies to the majority of infections.

What is the difference between high-risk and low-risk HPV strains?

Not all HPV types behave the same way, and knowing which category applies to a result shapes follow-up decisions.

• Low-risk strains (such as types 6 and 11) are associated with genital warts. These are treatable and not linked to cancer.
• High-risk strains (such as types 16 and 18) can, in a small minority of people, cause changes in cervical, anal, throat, penile, vaginal, or vulvar cells over many years if not monitored 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.HPV natural history, strain classification (low-risk vs high-risk), treatment of genital warts, immune clearance, and monitoring recommendations for immunocompromised individuals.

Cervical cancer is the most-studied consequence. With regular screening, abnormal cell changes (dysplasia) are almost always identified and treated long before cancer develops 2Ref 2US Preventive Services Task Force (2018).Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.Cervical cancer screening schedule for ages 21–65 using Pap smears or co-testing with HPV, and the ability to detect abnormal changes before progression to cancer. The USPSTF recommends cervical cancer screening for people aged 21–65 using Pap smears alone or co-testing with HPV 2Ref 2US Preventive Services Task Force (2018).Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement.Cervical cancer screening schedule for ages 21–65 using Pap smears or co-testing with HPV, and the ability to detect abnormal changes before progression to cancer.

What can and cannot be treated?

There is no pill or injection that clears the HPV virus itself. What can be treated are its visible effects:

• Genital warts can be removed through topical medications, cryotherapy (freezing), or minor procedures 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.HPV natural history, strain classification (low-risk vs high-risk), treatment of genital warts, immune clearance, and monitoring recommendations for immunocompromised individuals.
• Abnormal cervical cells identified on colposcopy or biopsy can be treated with procedures that remove or destroy affected tissue, preventing progression 3Ref 3American College of Obstetricians and Gynecologists (2023).Colposcopy and Cervical Biopsies (Patient FAQ).Follow-up colposcopy and biopsy for abnormal cervical cell changes, and treatment procedures to prevent progression.

For most people without symptoms or abnormal test results, the recommendation is watchful waiting — monitoring with regular Pap and HPV co-tests on the schedule a clinician recommends.

Does the HPV vaccine help if you already have HPV?

The HPV vaccine (such as Gardasil 9) works best before any exposure but can still offer partial protection to people who have already been infected, because it protects against strains not yet encountered.

Current ACIP guidelines recommend vaccination up to age 26 for all people, and consider vaccination for adults aged 27 to 45 after an individualized clinician conversation 4Ref 4Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019).Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.HPV vaccination recommendations up to age 26 for all, shared decision-making for ages 27–45, and partial protection for those with existing infection. The vaccine does not treat an existing infection, but it meaningfully reduces the risk of acquiring additional high-risk strains 4Ref 4Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE (2019).Human Papillomavirus Vaccination for Adults: Updated Recommendations of the Advisory Committee on Immunization Practices.HPV vaccination recommendations up to age 26 for all, shared decision-making for ages 27–45, and partial protection for those with existing infection.

Smoking is associated with slower HPV clearance and higher dysplasia risk — quitting is strongly encouraged for anyone managing an HPV diagnosis.

What does regular follow-up look like?

If you have had an abnormal HPV or Pap result, your clinician will recommend a specific follow-up schedule — typically a repeat test in one to three years, or a colposcopy if changes are more significant 3Ref 3American College of Obstetricians and Gynecologists (2023).Colposcopy and Cervical Biopsies (Patient FAQ).Follow-up colposcopy and biopsy for abnormal cervical cell changes, and treatment procedures to prevent progression. Following that schedule is the most important action available.

People with weakened immune systems — including those living with HIV, on immunosuppressive medications, or post-organ transplant — are less likely to clear HPV naturally and are typically monitored more frequently 1Ref 1Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA (2021).Sexually Transmitted Infections Treatment Guidelines, 2021.HPV natural history, strain classification (low-risk vs high-risk), treatment of genital warts, immune clearance, and monitoring recommendations for immunocompromised individuals. Most abnormal results never progress to anything serious; the screening system exists to catch the rare cases that do, early, when treatment is straightforward.